Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients

Figure 1 Survival curve of gastric cancer patients with low hemoglobin to albumin ratio and high hemoglobin to albumin ratio. HAR: Hemoglobin to albumin ratio; HR: Hazard ratio.

Figure 2 Association between hemoglobin to albumin ratio and clinicopathological characteristics, including grade, stage, T classification, N classification, tumor size, vascular infiltration, nerve infiltration and age. HAR: Hemoglobin to albumin ratio.

Figure 3 Relationships between hemoglobin to albumin ratio and prognostic factors, including stage, T classification, and tumor size, CA125, fibrinogen to lymphocyte ratio, platelet to albumin ratio, platelet to lymphocyte ratio and hemoglobin to fibrinogen ratio. HAR: Hemoglobin to albumin ratio; FLR: Fibrinogen to lymphocyte ratio; HFR: Hemoglobin to fibrinogen ratio; PAR: Platelet to albumin ratio; PLR: Platelet to lymphocyte ratio.

Figure 4 Receiver operating characteristic curve of hemoglobin to albumin ratio or combined factors to predict the short-term survival of gastric cancer patients. HAR: Hemoglobin to albumin ratio; AUC: Area under the curve.

Figure 5 Nomogram of the logistic regression model. HAR: Hemoglobin to albumin ratio.